Fewer than one-third of Chinese patients with acute coronary syndromes (ACS) receive guidance to participate in cardiac rehabilitation, according to research presented Oct. 11 at the Great Wall International Congress of Cardiology.
Preliminary results from the RETAKO trial, a study of takotsubo syndrome (TTS) in the Spanish population, have identified cardiogenic shock as an independent, strong predictor of mortality and complexities in TTS patients—a demographic that’s already at considerable risk for complications.
People with unrecognized myocardial infarction carry a lower short-term risk of death but an equal 10-year risk of mortality compared to those with clinically diagnosed heart attacks, according to an analysis of the ICELAND MI study published in JAMA Cardiology.
In light of Hurricane Michael’s destructive landfall Wednesday in the Florida panhandle, the American Heart Association is warning cardiovascular patients to plan ahead for unexpected emergencies, as they could be at an increased risk for CVD events during the storm.
Three men with type 2 diabetes used intermittent fasting to lose weight, lower their blood sugar levels and reverse their dependence on insulin treatment, according to a case study report published in The BMJ.
E-cigarettes have been touted as a way to help people stop using combustible cigarettes, but a new analysis in the Annals of Internal Medicine estimates 1.9 million American adults who vape have never smoked tobacco cigarettes.
Socioeconomic factors—namely a mother’s insurance status and level of education—weigh heavily on Hispanic infants’ chances of surviving critical congenital heart disease (CHD) in their first year of life, a study out of the University of California, San Francisco suggests.
MRI measurements of carotid wall thickness improve predictions of cardiovascular disease risk more than a commonly used ultrasound-based test, according to research published Oct. 9 in Radiology.
Direct oral anticoagulants (DOACs) can cut the short-term risk of thromboembolic events in half for patients who have undergone cardioversion of atrial fibrillation (AFib), suggests a meta-analysis published in the Journal of the American College of Cardiology.
In spite of recent research suggesting statins might carry some benefit for non-CVD patients, a review published in the Annals of Internal Medicine this week concluded they have no role outside of heart disease and could, in some cases, even increase patients’ risk for diabetes and myopathy.
